Health Officials Intensify Zika Prevention Efforts ARLINGTON, VA—State and territorial health officials are redoubling prevention efforts to address the serious public health threats associated with ...
On Jan. 30, 2023, ASTHO released a statement commending the FDA on a new proposal to conduct individual risk assessments for blood donors, a policy that reflects the best available science while not ...
ASTHO Commends the Surgeon General Advisory about Marijuana Use on the Developing Brain ARLINGTON, VA—Michael Fraser, Chief Executive Officer of the Association of State and Territorial Health ...
ASTHO Urges Swift Approval of Bipartisan Budget Deal ARLINGTON, VA—The Association of State and Territorial Health Officials (ASTHO) applauds the bipartisan budget deal to increase funding for ...
ASTHO Statement on House FY20 Appropriations Bill ARLINGTON, VA—Michael Fraser, chief executive officer of ASTHO, issued the following statement applauding the House FY20 Labor, Health and Human ...
Walgreens and Rite Aid Make Good Public Health Move on Raising Age to Purchase Tobacco, but More Is Needed ARLINGTON, VA—Nicole Alexander-Scott, MD, MPH, director of the Rhode Island Department of ...
State and Local Health Officials at the Capitol to Urge Congress to Prioritize Funding for Public Health ARLINGTON, VA—Over 80 state, local, and territorial health officials from across the country ...
Current Measles Outbreaks Should Alarm Every American and Highlight the Critical Importance of Vaccination Programs ARLINGTON, VA—John Wiesman, DrPH, MPH, secretary of health at the Washington State ...
On Aug. 11, 2022, ASTHO's Chief Medical Officer issued a statement of support for CDC's new COVID-19 guidelines.
On Feb. 26, 2024, ASTHO's CMO issued a statement in response to several measles outbreaks currently occurring in the United States.
On Oct. 4, 2023, ASTHO, CDC, the Center for Law and Social Policy, and Mental Health America released a framework for public health leaders with effective strategies to improve mental health and ...
On April 12, 2023, ASTHO released a statement applauding the Office of National Drug Control Policy’s announcement designating fentanyl adulterated or associated with xylazine as an emerging drug ...
ASTHO Applauds Administration's Commitment to Combat the Opioid Epidemic ARLINGTON, VA—Michael Fraser, executive director of ASTHO, issued the following response to HHS Secretary Tom Price’s ...
On March 23, 2023, ASTHO President Anne Zink testified before the U.S. House of Representatives Appropriations Subcommittee on Labor, Health and Human Services, Education, and Related Agencies.
Journal of Public Health Management and Practice Releases Studies Analyzing Largest Ever Public Health Workforce Survey
ASTHO Executive Director Michael Fraser Responds to the Affordable Care Act Replacement Bill ARLINGTON, VA—“While millions of Americans may experience changes in their insurance coverage as part of ...
State and Territorial Health Leaders Praise Surgeon General’s Report on E-Cigarettes ARLINGTON, VA—The Association of State and Territorial Health Officials (ASTHO) praises U.S. Surgeon General Vivek ...
ASTHO Statement on President Trump’s Fiscal Year 2018 Budget ARLINGTON, VA—Michael Fraser, executive director of ASTHO, issued the following statement on President Trump’s Fiscal Year 2018 budget, “A ...
Vital Public Health Programs will be Eliminated with Passage of AHCA ARLINGTON, VA—Michael Fraser, executive director of ASTHO, issued the following statement on the American Health Care Act: “With ...
State and Territorial Health Agencies Play Critical Role in Addressing Antimicrobial Resistance ARLINGTON, VA—As the threat of antimicrobial resistance (AMR) rises throughout the world, the White ...